AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7808826 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated skin)
Number of subjects: 15
Study 3400902 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (Medrol tablets, Upjohn)
Number of subjects: 29
Study 3400902 — intervention group
Group type: COMPARATOR
Intervention: Topical vasoconstrictor (oxymetazoline spray)
Number of subjects: 29
Study 3400902 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 29
Study 30562068 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 9249
Study 30562068 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 9249
Study 26681272 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil patch
Number of subjects: 101
Study 26681272 — intervention group
Group type: COMPARATOR
Intervention: Control (no TachoSil patch)
Number of subjects: 101
Study 24275775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% with epinephrine (10 µg/mL), injected at 5.4 mL (54 µg epinephrine) for group I and 10.8 mL (108 µg epinephrine) for group II.
Number of subjects: 26
Study 24275775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% with epinephrine (108 µg) in group II.
Number of subjects: 26
Study 24275775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% with epinephrine (54 µg) in group I.
Number of subjects: 26
Study 23676529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 23676529 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitor (SSRI)
Number of subjects: 0
Study 23676529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy + Selective Serotonin Reuptake Inhibitor (CBT+SSRI)
Number of subjects: 0
Study 23676529 — intervention group
Group type: COMPARATOR
Intervention: Control (CBT)
Number of subjects: 0
Study 20639274 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle programme (e.g. physical exercise, smoking cessation, dietary advice, including stress management)
Number of subjects: 130
Study 20639274 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 130
Study 20639274 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 130
Study 18407943 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 36
Study 18407943 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 36
Study 16603428 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (flare-up) protocol
Number of subjects: 30
Study 16603428 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist protocol
Number of subjects: 30
Study 16603428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received exogenous LH (human menopausal gonadotropin)
Number of subjects: 30
Study 14998094 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential anchoring technique (anchor group)
Number of subjects: 41
Study 14998094 — intervention group
Group type: COMPARATOR
Intervention: Non-anchor group (control)
Number of subjects: 41
Study 11148442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 6
Study 11148442 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 6
Study 9752737 — intervention group
Group type: EXPERIMENTAL
Intervention: Uranoplasty (surgical intervention)
Number of subjects: 0
Study 9752737 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive measures (aimed at removal or alleviation of alkalosis)
Number of subjects: 0
Study 7824809 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol, inhaled, twice daily for 12 weeks
Number of subjects: 99
Study 7824809 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol, inhaled, four times daily for 12 weeks
Number of subjects: 99
Study 3043414 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorionic Villus Sampling (CVS)
Number of subjects: 511
Study 3043414 — intervention group
Group type: COMPARATOR
Intervention: Amniocentesis (GA)
Number of subjects: 511
Study 3043414 — intervention group
Group type: COMPARATOR
Intervention: Chorionic Villus Sampling (CVS) and Amniocentesis (GA)
Number of subjects: 511
Study 31434144 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-strand grafts (T group)
Number of subjects: 76
Study 31434144 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-strand grafts (F group)
Number of subjects: 76
Study 29952176 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week jazz dance class (two times/week for 70 min per session)
Number of subjects: 90
Study 28456146 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypodium leucotomos/pomegranate combination (PPmix®) 480 mg/day
Number of subjects: 40
Study 28456146 — intervention group
Group type: COMPARATOR
Intervention: Polypodium leucotomos alone (Fernblock®) 480 mg/day
Number of subjects: 40
Study 26297156 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonists (triptorelin injections of 0.1mg on the 4th and 6th day after progesterone introduction)
Number of subjects: 220
Study 26297156 — intervention group
Group type: COMPARATOR
Intervention: Usual progesterone supplementation
Number of subjects: 220
Study 23663119 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (150 mg/day)
Number of subjects: 10
Study 23663119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 21724628 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily interruption of fentanyl and/or midazolam infusions for up to 6 hours
Number of subjects: 50
Study 21724628 — intervention group
Group type: COMPARATOR
Intervention: Usual management of sedation
Number of subjects: 50
Study 19357910 — intervention group
Group type: EXPERIMENTAL
Intervention: BTX‐A (2.5 U per cubic centimeter of lesion) injected for a total of 3 months
Number of subjects: 19
Study 16961787 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (25 mg to 100 mg daily, titrated by week 4)
Number of subjects: 51
Study 16961787 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 51
Study 12764513 — intervention group
Group type: EXPERIMENTAL
Intervention: Shanghai Chronic Disease Self‐Management Program (CDSMP)
Number of subjects: 954
Study 12764513 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting-list)
Number of subjects: 954
Study 11071034 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg clonidine
Number of subjects: 44
Study 11071034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 9305267 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-length custom-made shoes with a total-contact insert, a rigid rocker-bottom sole
Number of subjects: 30
Study 9305267 — intervention group
Group type: EXPERIMENTAL
Intervention: Short shoe with a rigid rocker-bottom sole (with or without an ankle-foot-orthosis)
Number of subjects: 30
Study 9305267 — intervention group
Group type: COMPARATOR
Intervention: Regular shoes with a toe filler
Number of subjects: 30
Study 9305267 — intervention group
Group type: EXPERIMENTAL
Intervention: Short shoe and ankle-foot-orthosis
Number of subjects: 30
Study 9305267 — intervention group
Group type: EXPERIMENTAL
Intervention: All footwear conditions
Number of subjects: 30
Study 8369246 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (100 micrograms inserted vaginally)
Number of subjects: 45
Study 8369246 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similarly inserted)
Number of subjects: 45
Study 3531295 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice daily
Number of subjects: 99
Study 3531295 — intervention group
Group type: COMPARATOR
Intervention: Captopril 25 mg plus hydrochlorothiazide 15 mg
Number of subjects: 99
Study 3531295 — intervention group
Group type: COMPARATOR
Intervention: Captopril 50 mg twice daily
Number of subjects: 99
Study 31964193 — intervention group
Group type: EXPERIMENTAL
Intervention: PUMPA‐TURP
Number of subjects: 80
Study 31964193 — intervention group
Group type: COMPARATOR
Intervention: Traditional TURP
Number of subjects: 80
Study 30531187 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfocused Ultrasound with Visualization (MFU-V)
Number of subjects: 20
Study 30531187 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar Radiofrequency (MRF)
Number of subjects: 20
Study 30531187 — intervention group
Group type: COMPARATOR
Intervention: Both MRF and MFU-V
Number of subjects: 20
Study 28708420 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/kg BW Tualang Honey (high honey; HH; n=10)
Number of subjects: 20
Study 28708420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 g/kg BW Tualang Honey (low honey; LH; n=10)
Number of subjects: 20
Study 25822284 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Centered Disease Management (PCDM) intervention
Number of subjects: 392
Study 25822284 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 392
Study 24376252 — intervention group
Group type: COMPARATOR
Intervention: Dietary Guidelines (DG) only group (n = 61)
Number of subjects: 121
Study 24376252 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Guidelines + Physical Activity (DG + PA) group (n = 60)
Number of subjects: 121
Study 22804826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin eardrops
Number of subjects: 159
Study 22804826 — intervention group
Group type: EXPERIMENTAL
Intervention: Boric acid powder
Number of subjects: 159
Study 22804826 — intervention group
Group type: COMPARATOR
Intervention: 1% Acetic acid eardrops
Number of subjects: 159
Study 22804826 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriderm cream
Number of subjects: 159
Study 18716827 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical piroxicam
Number of subjects: 50
Study 18716827 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 50
Study 18217459 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice policosanol 10 mg/day
Number of subjects: 66
Study 18217459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 15170705 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational angiography
Number of subjects: 56
Study 15170705 — intervention group
Group type: COMPARATOR
Intervention: Standard angiography
Number of subjects: 56
Study 11354594 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐month work rehabilitation program
Number of subjects: 33
Study 11354594 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological variables
Number of subjects: 33
Study 11354594 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological measures
Number of subjects: 33
Study 9549666 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 0
Study 9549666 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (40 mg)
Number of subjects: 0
Study 9549666 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil and Methylphenidate (combination)
Number of subjects: 0
Study 8045961 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin (GnRH agonist) for 9 months
Number of subjects: 20
Study 8045961 — intervention group
Group type: COMPARATOR
Intervention: Estrogen plus progestin replacement from the fourth month onward
Number of subjects: 20
Study 2648890 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 100 mg suppository
Number of subjects: 30
Study 2648890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30421240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation
Number of subjects: 62
Study 30421240 — intervention group
Group type: COMPARATOR
Intervention: Manual ventilation
Number of subjects: 62
Study 29738179 — intervention group
Group type: EXPERIMENTAL
Intervention: Gujing Maisiha Tablets combined with natural vitamin E
Number of subjects: 135
Study 29738179 — intervention group
Group type: COMPARATOR
Intervention: Natural vitamin E only (Control)
Number of subjects: 135
Study 25874955 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 80
Study 25874955 — intervention group
Group type: COMPARATOR
Intervention: Supportive psychotherapy (SPT)
Number of subjects: 80
Study 23680241 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 20
Study 23680241 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients (4-7 years duration)
Number of subjects: 20
Study 23680241 — intervention group
Group type: COMPARATOR
Intervention: Non-diabetic patients
Number of subjects: 20
Study 21414223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mononuclear bone marrow cells (mBMC)
Number of subjects: 15
Study 21414223 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study 19968014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 51
Study 19968014 — intervention group
Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 51
Study 19968014 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (crossed over to CBT-I)
Number of subjects: 51
Study 16828803 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 50 or 500 mg
Number of subjects: 100
Study 16828803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 15176649 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg subcutaneously twice weekly for 12 weeks
Number of subjects: 43
Study 15176649 — intervention group
Group type: COMPARATOR
Intervention: Data from prior clinical studies (healthy subjects n=53, RA patients n=212)
Number of subjects: 43
Study 15663647 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral (Novartis)
Number of subjects: 38
Study 15663647 — intervention group
Group type: COMPARATOR
Intervention: Cysporin (Mayne Pharma)
Number of subjects: 38
Study 10077095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine injected by high-pressure technique
Number of subjects: 20
Study 10077095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine injected by low-pressure technique
Number of subjects: 20
Study 10077095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine without epinephrine injected under high pressure
Number of subjects: 20
Study 10077095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine without epinephrine injected under low pressure
Number of subjects: 20
Study 7737398 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal vision
Number of subjects: 6
Study 7737398 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes closed (remembered location of the target)
Number of subjects: 6
Study 7737398 — intervention group
Group type: EXPERIMENTAL
Intervention: Flanker objects present (wooden cylinder)
Number of subjects: 6
Study 2285719 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural analgesia
Number of subjects: 134
Study 2285719 — intervention group
Group type: COMPARATOR
Intervention: Normal saline epidural solution
Number of subjects: 134
Study 7306862 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% methylcellulose
Number of subjects: 120
Study 7306862 — intervention group
Group type: COMPARATOR
Intervention: Paraffin-based oculentum simplex
Number of subjects: 120
Study 31635962 — intervention group
Group type: EXPERIMENTAL
Intervention: Branches
Number of subjects: 158
Study 31635962 — intervention group
Group type: COMPARATOR
Intervention: Fenestrations
Number of subjects: 158
Study 31140402 — intervention group
Group type: EXPERIMENTAL
Intervention: Early endovenous ablation (compression therapy and superficial endovenous ablation within 2 weeks of randomisation)
Number of subjects: 450
Study 31140402 — intervention group
Group type: COMPARATOR
Intervention: Deferred endovenous ablation (compression therapy followed by endovenous ablation once the ulcer had healed)
Number of subjects: 450
Study 31140402 — intervention group
Group type: EXPERIMENTAL
Intervention: Early endovenous ablation
Number of subjects: 450
Study 31140402 — intervention group
Group type: COMPARATOR
Intervention: Deferred endovenous ablation
Number of subjects: 450
Study 28891084 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitian group (DG)
Number of subjects: 100
Study 28891084 — intervention group
Group type: COMPARATOR
Intervention: Physician group (PG)
Number of subjects: 100
Study 26709105 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG simulator program
Number of subjects: 0
Study 26709105 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching
Number of subjects: 0
Study 24356398 — intervention group
Group type: EXPERIMENTAL
Intervention: Full periodontal therapy (Group 1, n = 15)
Number of subjects: 25
Study 24356398 — intervention group
Group type: COMPARATOR
Intervention: No professional periodontal cleaning (Group 2, n = 10)
Number of subjects: 25
Study 23202818 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic BioSand filter (BSF)
Number of subjects: 0
Study 20815045 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 169
Study 20815045 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 169
Study 17945291 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin combined with 0.5 mg/kg furosemide daily
Number of subjects: 12
Study 17945291 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin alone
Number of subjects: 12
Study 17945291 — intervention group
Group type: COMPARATOR
Intervention: Dietary sodium and protein restriction
Number of subjects: 12
Study 16256917 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrub-and-paint (n = 115)
Number of subjects: 234
Study 16256917 — intervention group
Group type: COMPARATOR
Intervention: Paint-only (n = 119)
Number of subjects: 234
Study 11830801 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated varicella vaccine
Number of subjects: 461
Study 10190788 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 1-hour infusion
Number of subjects: 0
Study 10190788 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 3-hour infusion
Number of subjects: 0
Study 10190788 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimation of glomerular filtration rate using age, height, plasma creatinine, and plasma creatine kinase
Number of subjects: 0
Study 10190788 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 gene sequence analysis
Number of subjects: 0
Study 7757101 — intervention group
Group type: EXPERIMENTAL
Intervention: White women
Number of subjects: 0
Study 7757101 — intervention group
Group type: EXPERIMENTAL
Intervention: White men
Number of subjects: 0
Study 7757101 — intervention group
Group type: COMPARATOR
Intervention: Black women
Number of subjects: 0
Study 31460771 — intervention group
Group type: EXPERIMENTAL
Intervention: Panchatikta Ghrita (PG) with calcium and vitamin D3 supplements
Number of subjects: 80
Study 31460771 — intervention group
Group type: COMPARATOR
Intervention: Calcium and vitamin D3 supplements
Number of subjects: 80
Study 28510346 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivipansel 4 g by intravenous infusion over 20 minutes
Number of subjects: 48
Study 28510346 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 48
Study 28510346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 26265201 — intervention group
Group type: EXPERIMENTAL
Intervention: CRIS with tailored printouts
Number of subjects: 0
Study 26265201 — intervention group
Group type: EXPERIMENTAL
Intervention: CRIS with standard information
Number of subjects: 0
Study 26265201 — intervention group
Group type: COMPARATOR
Intervention: No-contact group
Number of subjects: 0
Study 26265201 — intervention group
Group type: EXPERIMENTAL
Intervention: CRIS tailored group (ages 50 and older)
Number of subjects: 0
Study 26265201 — intervention group
Group type: EXPERIMENTAL
Intervention: CRIS nontailored group (ages 50 and older)
Number of subjects: 0
Study 23353631 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 2112
Study 23353631 — intervention group
Group type: COMPARATOR
Intervention: Not treated with hydrochlorothiazide
Number of subjects: 2112
Study 21975090 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 406
Study 21975090 — intervention group
Group type: COMPARATOR
Intervention: Health education intervention
Number of subjects: 406
Study 19906312 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-disciplinary orientation program including face-to-face introduction to hospital facilities, multi-disciplinary team, treatment side effects, and self-care strategies.
Number of subjects: 0
Study 19906312 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 16984385 — intervention group
Group type: EXPERIMENTAL
Intervention: DN-101 (high dose calcitriol) with docetaxel
Number of subjects: 250
Study 16984385 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (placebo-controlled)
Number of subjects: 250
Study 15259289 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg 17beta-estradiol combined with 1, 2 or 3 mg drospirenone daily
Number of subjects: 180
Study 15259289 — intervention group
Group type: COMPARATOR
Intervention: 1 mg drospirenone
Number of subjects: 180
Study 10790458 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma education and medical treatment in the setting of a tertiary care pediatric allergy clinic with monthly contact from an asthma outreach nurse.
Number of subjects: 80
Study 10790458 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 80
Study 9071565 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-inflammatory cytokines (IL-6, IL-8, TNF-alpha)
Number of subjects: 23
Study 9071565 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory cytokines (IL-10, TNFsrI, TNFsrII)
Number of subjects: 23
Study 9071565 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum nitrate levels
Number of subjects: 23
Study 9071565 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum nitrate levels in patients with positive blood cultures (n = 4)
Number of subjects: 23
Study 8379858 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol gel (1.25 g)
Number of subjects: 61
Study 8379858 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol gel (2.5 g)
Number of subjects: 61